Norway · Delayed Price · Currency is NOK EXACT Therapeutics AS Company Description
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a novel ultrasound-mediated technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT) in Norway.
The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various applications, including oncology, neurological conditions, and gene therapy.
The company’s ACT platform is under Phase 2 clinical trial for the treatment of pancreatic disease; Phase I clinical trial for treatment of liver metastases; and pre-clinical studies for glioblastoma, and immunotherapy diseases, as well as CNS diseases and gene therapy.
It has a collaboration with GE Healthcare. The company was formerly known as Phoenix Solutions AS.
EXACT Therapeutics AS was founded in 2012 and is based in Oslo, Norway.
| Country | Norway |
| Founded | 2012 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Per Walday |
Contact Details
Address: Østre Aker vei 19 Oslo, 0581 Norway | |
| Website | exact-tx.com |
Stock Details
| Ticker Symbol | EXTX |
| Exchange | Oslo Børs |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| ISIN Number | NO0010852213 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Per Edvard Walday Ph.D. | Chief Executive Officer |
| Dr. Svein Kvåle | Co-Founder and Chief Operating Officer |
| John M. Edminson | Chief Financial Officer |
| Dr. Masha Paule Nathalie Legris Stromme DPHIL | Director |
| Dr. Amir Snapir M.D., Ph.D. | Chief Medical Officer |
| Caspar Foghsgaard | Chief Business Officer |
| Dr. Per Christian Sontum | Founder |
| Ragnar Bendicksen | Vice President of Technology |